The objective of this study is to evaluate the safety and effectiveness of administering high-dose chemotherapy followed by infusion of autologous CD34-selected peripheral blood stem cells (PBSC) in pediatric and adult patients with severe Crohn's disease.
The objective of this study is to evaluate the safety and effectiveness of administering high-dose chemotherapy followed by infusion of autologous CD34-selected peripheral blood stem cells (PBSC) in pediatric and adult patients with severe Crohn's disease.
Autologous Stem Cell Transplantation for Crohn's Disease
-
UPMC Prebyterian- Adult Gastroenterology, Pittsburgh, Pennsylvania, United States, 15213
Children's Hospital of Pittsburgh of UPMC-Bone Marrow Team, Pittsburgh, Pennsylvania, United States, 15224
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
10 Years to 60 Years
ALL
No
Paul Szabolcs,
Paul Szabolcs, MD, PRINCIPAL_INVESTIGATOR, University of Pittsburgh
2026-12